3-Ethyl-3-propyl-1-prop-2-ynyl-2,4-dihydro-1,3,5-triazin-3-ium

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: 3-Ethyl-3-propyl-1-prop-2-ynyl-2,4-dihydro-1,3,5-triazin-3-ium
• 英文别名: 3-ethyl-3-propyl-1-prop-2-ynyl-2,4-dihydro-1,3,5-triazin-3-ium
• 化学式: C11H20N3+
• 分子量: 194.3
• InChiKey: FREOKPVGKRHUAD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  15.6
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• NOVEL ORALLY BIOAVAILABLE BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME
  申请人：Galleon Pharmaceuticals, Inc.

  公开号：EP2920155A2

  公开（公告）日：2015-09-23
• [EN] NOVEL ORALLY BIOAVAILABLE BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME<br/>[FR] NOUVEAUX COMPOSÉS DE MODULATION DE RÉGULATION DE LA RESPIRATION ORALEMENT BIODISPONIBLES ET LEURS PROCÉDÉS D'UTILISATION
  申请人：GALLEON PHARMACEUTICALS INC

  公开号：WO2014078575A2

  公开（公告）日：2014-05-22

  The present invention includes compositions that are useful in the prevention and/or treatment of breathing control diseases or disorders in a subject in need thereof. The present invention also includes a method of preventing and/or treating a respiratory disease or disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition of the invention. The present invention further includes a method of preventing destabilization or stabilizing breathing rhythm in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition of the invention.